×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
UPB – upstream bio, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
UPB
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
3/5
05:46 pm
upb
Chronic Rhinosinusitis with Nasal Polyps Market Shows Strong Upward Momentum During the Forecast Period (2026-2036) as Demand for Advanced Therapies Rises | DelveInsight [Yahoo! Finance]
Low
Report
Chronic Rhinosinusitis with Nasal Polyps Market Shows Strong Upward Momentum During the Forecast Period (2026-2036) as Demand for Advanced Therapies Rises | DelveInsight [Yahoo! Finance]
3/1
10:03 am
upb
Upstream Bio Presents Additional Analyses from the Phase 2 VIBRANT Trial of Verekitug in Chronic Rhinosinusitis with Nasal Polyps at 2026 AAAAI Annual Meeting [Yahoo! Finance]
Neutral
Report
Upstream Bio Presents Additional Analyses from the Phase 2 VIBRANT Trial of Verekitug in Chronic Rhinosinusitis with Nasal Polyps at 2026 AAAAI Annual Meeting [Yahoo! Finance]
3/1
09:45 am
upb
Upstream Bio Presents Additional Analyses from the Phase 2 VIBRANT Trial of Verekitug in Chronic Rhinosinusitis with Nasal Polyps at 2026 AAAAI Annual Meeting
Neutral
Report
Upstream Bio Presents Additional Analyses from the Phase 2 VIBRANT Trial of Verekitug in Chronic Rhinosinusitis with Nasal Polyps at 2026 AAAAI Annual Meeting
2/26
07:32 am
upb
Upstream Bio to Present Additional Analyses from Phase 2 VIBRANT Trial in Chronic Rhinosinusitis with Nasal Polyps in Late-Breaking Session at AAAAI Annual Meeting 2026 [Yahoo! Finance]
Low
Report
Upstream Bio to Present Additional Analyses from Phase 2 VIBRANT Trial in Chronic Rhinosinusitis with Nasal Polyps in Late-Breaking Session at AAAAI Annual Meeting 2026 [Yahoo! Finance]
2/26
07:00 am
upb
Upstream Bio to Present Additional Analyses from Phase 2 VIBRANT Trial in Chronic Rhinosinusitis with Nasal Polyps in Late-Breaking Session at AAAAI Annual Meeting 2026
Low
Report
Upstream Bio to Present Additional Analyses from Phase 2 VIBRANT Trial in Chronic Rhinosinusitis with Nasal Polyps in Late-Breaking Session at AAAAI Annual Meeting 2026
2/25
07:00 am
upb
Upstream Bio to Participate in Upcoming March Investor Conferences
Medium
Report
Upstream Bio to Participate in Upcoming March Investor Conferences
2/12
02:02 pm
upb
Upstream Bio: Hold Rating As Verekitug Faces Competition Among Latest Asthma Data [Seeking Alpha]
Low
Report
Upstream Bio: Hold Rating As Verekitug Faces Competition Among Latest Asthma Data [Seeking Alpha]
2/11
06:00 am
upb
Upstream Bio Reports Positive Top-line Results from the Phase 2 VALIANT Trial of Verekitug for the Treatment of Severe Asthma
High
Report
Upstream Bio Reports Positive Top-line Results from the Phase 2 VALIANT Trial of Verekitug for the Treatment of Severe Asthma
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
2/11
09:17 am
upb
Form 8-K Upstream Bio, Inc. For: Feb 11
High
Report
Form 8-K Upstream Bio, Inc. For: Feb 11
2/11
06:39 am
upb
Form 8-K Upstream Bio, Inc. For: Feb 11
High
Report
Form 8-K Upstream Bio, Inc. For: Feb 11
1/6
05:15 pm
upb
Form 4 Upstream Bio, Inc. For: Jan 02 Filed by: Houghton Adam
Medium
Report
Form 4 Upstream Bio, Inc. For: Jan 02 Filed by: Houghton Adam
1/6
05:15 pm
upb
Form 4 Upstream Bio, Inc. For: Jan 02 Filed by: Deykin Aaron
Medium
Report
Form 4 Upstream Bio, Inc. For: Jan 02 Filed by: Deykin Aaron
1/6
05:15 pm
upb
Form 4 Upstream Bio, Inc. For: Jan 02 Filed by: Sutherland Everett Rand
Medium
Report
Form 4 Upstream Bio, Inc. For: Jan 02 Filed by: Sutherland Everett Rand
1/6
05:15 pm
upb
Form 4 Upstream Bio, Inc. For: Jan 02 Filed by: GRAY MICHAEL
Medium
Report
Form 4 Upstream Bio, Inc. For: Jan 02 Filed by: GRAY MICHAEL
1/6
05:15 pm
upb
Form 4 Upstream Bio, Inc. For: Jan 02 Filed by: Ambrose Allison
Medium
Report
Form 4 Upstream Bio, Inc. For: Jan 02 Filed by: Ambrose Allison
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: